Some patients reporting COVID rebounds after taking Pfizer pills

More than 2.8 million courses of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United States, with…

Related Keywords

United States ,Toronto ,Ontario ,Canada ,American ,Mikael Dolsten ,William Pao ,Albert Bourla ,Caroline Humer ,Pfizer ,Us Centers For Disease ,Pfizer Inc ,Postmedia Network Inc ,Drug Administration ,Reuters ,Chief Development Officer William Pao ,Executive Albert Bourla ,Disease Control ,Michael Erman ,Bill Berkrot ,Postmedia Network ,Street East ,